Disruptive Pharma AB

Disruptive Pharma AB

0.08
EUR
0.00
(0.00%)
-0.01EPS
6.14MMarket Cap
Feb 18Next Earn

Total Valuation

EUR

As of March 31, 2026, Disruptive Pharma AB carries a market capitalization of 6.14M, placing it among publicly traded companies globally. Its enterprise value stands at 5.77M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap6.14M
Enterprise Value5.77M

Important Dates

Disruptive Pharma AB's next confirmed earnings release is scheduled for February 18, 2027.

Earnings Date2/18/2027

Share Statistics

As of March 31, 2026, Disruptive Pharma AB has 44.82M shares outstanding.

Shares Outstanding44.82M

Valuation Ratios

These figures are as of March 31, 2026.

PB Ratio19.34
P/TBV Ratio19.34

Financial Position

As of March 31, 2026, Disruptive Pharma AB maintains a current ratio of 2.14, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.

Current Ratio2.14
Quick Ratio1.52

Stock Price Statistics

EUR

As of the close on November 17, 2026, Disruptive Pharma AB's stock has declined approximately 33.73% over the past 52 weeks. The 50-day moving average sits at 0.10, while the 200-day moving average is 0.12.

52-Week Price Change-33.73%
50-Day Moving Average0.10
200-Day Moving Average0.12

Income Statement

EUR

These figures cover the twelve months ended March 31, 2026.

Pretax Income-308,624.53

Balance Sheet

EUR

These figures are as of March 31, 2026. Total book value stands at 317,405.79, with working capital of 278,804.86 providing operational flexibility.

Cash & Cash Equivalents373,294.82
Net Debt-373,294.82
Equity (Book Value)317,405.79
Book Value Per Share0.01
Working Capital278,804.86

Cash Flow

EUR

These figures cover the twelve months ended March 31, 2026.

Free Cash Flow-333,413.29
FCF Per Share-0.01

Margins

These figures cover the twelve months ended March 31, 2026. The operating margin of -575.38 and net profit margin of -572.84 provide insight into operational efficiency.

Operating Margin-575.38
Pretax Margin-572.84
Profit Margin-572.84

Stock Splits

Disruptive Pharma AB's most recent stock split took place on March 18, 2025 with a 725:756 split ratio.

Last Split Date3/18/2025
Split Ratio725:756